These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 7972793)
1. Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda. Wahl RL; Hawkins RA; Larson SM; Hendee WR; Coleman RE; Holden RW; Frick MP; Gatsonis C; Brown GS; Shtern F Radiology; 1994 Dec; 193(3):604-6. PubMed ID: 7972793 [No Abstract] [Full Text] [Related]
2. Complementary roles of PET and MR spectroscopy in the management of brain tumors. Alavi A; Alavi JB; Lenkinski RE Radiology; 1990 Dec; 177(3):617-8. PubMed ID: 2243960 [No Abstract] [Full Text] [Related]
3. The future of positron emission tomography in oncology depends on interactive basic, nuclear and clinical research. Buell U; Cremerius U; Zimny M Eur J Nucl Med; 1997 Oct; 24(10):1330. PubMed ID: 9432468 [No Abstract] [Full Text] [Related]
4. Tissue characterization in nuclear oncology: its time has come. Lamki LM J Nucl Med; 1995 Feb; 36(2):207-10. PubMed ID: 7830115 [No Abstract] [Full Text] [Related]
5. The heritage of radiotracers for positron emission tomography. Fowler JS; Wolf AP Acta Radiol Suppl; 1990; 374():13-6. PubMed ID: 1966960 [TBL] [Abstract][Full Text] [Related]
6. The evolution of positron emission tomography. Tilyou SM J Nucl Med; 1991 Apr; 32(4):15N-19N, 23N-26N. PubMed ID: 2013789 [No Abstract] [Full Text] [Related]
7. Is there a future for PET in oncology? Price P Eur J Nucl Med; 1997 Jun; 24(6):587-9. PubMed ID: 9235296 [No Abstract] [Full Text] [Related]
8. Imaging research in B.C.--a unique PET program. Pate B Dimens Health Serv; 1983 Jun; 60(6):31. PubMed ID: 6603991 [No Abstract] [Full Text] [Related]
9. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? Brock CS; Meikle SR; Price P Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580 [TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography in oncology. General acceptance of its role is overdue. Lamki LM Cancer; 1996 Nov; 78(10):2039-42. PubMed ID: 8918394 [No Abstract] [Full Text] [Related]
14. Present status of PET radiochemistry at Rossendorf. Steinbach J; Guenther K; Beyer GJ Acta Radiol Suppl; 1991; 376():119-20. PubMed ID: 1666742 [No Abstract] [Full Text] [Related]
15. Origins of the Patlak plot. Gjedde A Nucl Med Commun; 1995 Nov; 16(11):979-80. PubMed ID: 8587763 [No Abstract] [Full Text] [Related]
16. PET scanning in oncology. Wilson CB Eur J Cancer; 1992; 28(2-3):508-10. PubMed ID: 1591075 [No Abstract] [Full Text] [Related]
17. The Lung Cancer Study Group: Final analysis. Chest; 1994 Dec; 106(6 Suppl):279S-410S. PubMed ID: 7988243 [No Abstract] [Full Text] [Related]
18. PET scanning in clinical oncology. Timothy AR; Cook GJ Ann Oncol; 1998 Apr; 9(4):353-5. PubMed ID: 9636824 [No Abstract] [Full Text] [Related]
19. The national impact of clinical cooperative group trials for pediatric cancer. Murphy SB Med Pediatr Oncol; 1995 May; 24(5):279-80. PubMed ID: 7700177 [No Abstract] [Full Text] [Related]
20. Proceedings of the PET Data Analysis Workshop. New York, New York, 1-2 May 1989. J Cereb Blood Flow Metab; 1991 Mar; 11(2):A1-146. PubMed ID: 1997477 [No Abstract] [Full Text] [Related] [Next] [New Search]